Topical Analgesic Gel Manufacturing and Supply

The contract calls for the manufacture and supply of 4 oz (118 ml) tubes of a 5% Menthol USP topical analgesic gel, requiring full formulation development, rigorous quality control procedures, and strict adherence to FDA current Good Manufacturing Practices. All production must comply with military labeling standards, ensuring accurate, legible, and specification-compliant packaging and documentation suitable for federal use. The product is intended for delivery to a designated military installation in Watervliet, New York, with the manufacturing process subject to audit and verification to meet Department of Defense requirements. Responses are due by July 20, 2026, with the solicitation issued under the NAICS code 325412 for pharmaceutical and botanical product manufacturing. This is a subcontract opportunity managed by the Medical Supply Chain Pharm FSA within the Department of Defense, and while no set-aside type is specified, bidders must be prepared to demonstrate capability in large-scale pharmaceutical production, regulatory compliance, and timely fulfillment under the constraints of federal procurement protocols. All activities must align with the designated place of performance and meet the technical and administrative conditions outlined by the contracting authority.